Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The objective of this study is to examine the clinical dose range of ASP1585 based on the efficacy, safety, and feasibility of treatment in chronic kidney disease patients on hemodialysis with hyperphosphatemia.
Epistemonikos ID: e64ba3318027e606a7272f0d3e38ff671d8b6975
First added on: May 13, 2024